5 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the five most promising cancer stocks according to analysts.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | OrbiMed Advisors Samuel Isaly | 0 | $0 | 0% | |
2. | Laurion Capital Management Benjamin A. Smith | 0 | $0 | 0% | |
3. | 0 | $0 | 0% | ||
4. | 0 | $0 | 0% | ||
5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$3.05 | 151,450 | Large Shareholder, Director | 650,600 | 2023-07-17 | Filing | |
$3.05 | 328,482 | Large Shareholder, Director | 17,063,000 | 2023-07-17 | Filing | |
$3.05 | 151,450 | Large Shareholder, Director | 650,600 | 2023-07-17 | Filing | |
$3.05 | 328,482 | Large Shareholder, Director | 17,063,000 | 2023-07-17 | Filing | |
$2.97 | 176,550 | Large Shareholder | 1,385,825 | 2023-07-17 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 4,108,796 | $16,640,624 | 22.67% | |
2. | 2,118,051 | $8,578,107 | 0.45% | |
3. | 1,425,234 | $5,772,198 | 0% | |
4. | 1,108,320 | $4,488,696 | 3.39% | |
5. | 795,549 | $3,221,973 | 0% |